Iger Peginterferon Lambda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iger peginterferon lambda . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iger Peginterferon Lambda Today - Breaking & Trending Today

Eiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In Premarket

Eiger BioPharmaceuticals, Inc. (EIGR), a commercial-stage biopharmaceutical company focused on rare metabolic diseases, Wednesday said it has decided to discontinue the Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta or CHD. ....

David Apelian , Eiger Biopharmaceuticals Inc , More Such Health News , Eiger Biopharmaceuticals , Data Safety Monitoring Board , Peginterferon Lambda , Iger Peginterferon Lambda , Iger To Discontinue , Hd Patient , Rare Metabolic ,